Treatment with PRO2_ (PRO3_) prolongs survival of CML patients and is associated with a complete cytogenetic response in 5-33% of CML patients (1,2).
[Treatment;with;PRO2_]
[PRO2_; ;PRO3_]
[prolongs; ;survival]
[prolongs; ;Treatment]
[survival;of;patients]
[patients; ;CML]
[and; ;patients]
[and; ;associated]
[associated; ;is]
[associated with; ;response]
[response; ;cytogenetic]
[response; ;complete]
[response; ;a]
[response;in;5-33%]
[$;of;patients]
[patients; ;CML]
